TWST Trading Analysis - 11/02/2026 03:18 PM — TRU-SENTIMENT

News Headlines & Context

TWST (Twist Bioscience) has seen elevated attention following a volatile October where shares spiked to a 30-day high of $219.71 on 2026-10-05 before collapsing to the $130 range by early November. Recent general-knowledge context includes:

• Twist Bioscience announced expanded synthetic DNA production capacity in late September 2026, a catalyst behind the early-October rally above $200.
• Mid-October 2026 brought a sector-wide biotech selloff amid rising rates, coinciding with TWST's drop from $207.71 to below $150.
• No confirmed Q4 earnings date, but fiscal year-end was 2026-09-01 per fundamentals, suggesting upcoming annual filings could act as a volatility catalyst.
• High beta (2.48) and historical volatility (111.78%) indicate TWST remains prone to sharp moves on headline risk.

Context: The news-driven spike-and-collapse aligns with the embedded daily data showing a peak near $219.71 and subsequent decline to $130.26 by the last minute bar. Options sentiment is heavily bearish even as near-term technicals appear neutral, a divergence potentially rooted in post-rally caution.

Fundamental Analysis

Based strictly on the provided FUNDAMENTALS data for TWST:

• Trailing EPS is -$2.23 (negative); trailing PE, forward PE, PEG ratio, price-to-book, profit margins, ROE, debt-to-equity, and free cash flow are all null or unavailable.
• Revenue growth, total revenue, and analyst target mean price are not provided (null).
• Market cap is $8,636,368,260.00 with shares outstanding of 66,301,000.00; institutional ownership is 99.70%.
• Dividend yield is 0.00% with no dividend rate or ex-date.
• 52-week high is $219.71 and 52-week low is $23.30; beta is 2.48 (high systematic risk).
• Average volume is 2,997,000.00; historical volatility is 111.78%.

Key concerns: Persistent losses (negative EPS) and absent margin/valuation metrics make traditional fundamental grading impossible. Strengths: Near-total institutional sponsorship (99.70%) and large market cap. Fundamentals diverge from the technical picture, which shows price stabilizing near major SMAs; the lack of profitability contrasts with the stock's wide 52-week range ($23.30–$219.71) driven by speculative momentum.

Current Market Position

From the embedded data, the indicator current price is $154.26 (as of 2026-10-30). The last minute bar (2026-11-02 14:50:00) shows a close of $130.26, with the session ranging $129.64–$132.16, indicating a sharp late-period decline from the $160+ zone seen on 2026-10-30 intraday.

Daily history shows the stock closed at $154.26 on 2026-10-30 after opening at $162.94 and trading as low as $148.00. The 30-day range per indicators is high $219.71 / low $130.68, placing the last minute print ($130.26) just below the 30-day low boundary.

Intraday momentum (last 5 minute bars 2026-11-02) shows consecutive lower closes from $131.51 to $130.26 with modest volume (18k–40k), confirming weak short-term momentum into the close.

Technical Analysis

SMA trends: SMA 5 ($161.44) is above SMA 20 ($154.39) and SMA 50 ($153.32), but price ($154.26 indicator / $130.26 last minute) is below all three, signaling a bearish reversion despite longer-term alignment. No fresh crossover is shown; the 5-day is declining toward the 20/50.

RSI at 51.39 reflects neutral momentum, neither overbought nor oversold. MACD histogram is +0.16 (macd 0.79 vs signal 0.63), a mildly bullish stance on the dated indicator snapshot, though last-minute price action contradicts this.

Bollinger Bands: mid $154.39, upper $187.65, lower $121.14. Price near $130 is in the lower third, not a squeeze (wide bands imply expansion/volatility). The 30-day high/low context: last price $130.26 sits at the very bottom of the $130.68–$219.71 range.

True Sentiment Analysis (Delta 40-60 Options)

From the True Sentiment options file (2026-11-02 15:17):

Call Volume: $109,170.00 (11.80%) Put Volume: $813,600.00 (88.20%) Total: $922,770.00

Sentiment is Bearish. Only 20 of 522 total options met the Delta 40-60 filter (3.80%). Call contracts 60 vs put contracts 305, with 8 call trades and 12 put trades. The massive put dollar dominance (7.45x call size) shows strong directional conviction to the downside near-term.

Notable divergence: Technicals (RSI 51.39, MACD positive histogram) show no clear direction, while options flow is decisively bearish. The option spread recommendation file explicitly notes "Divergence detected between technical indicators and options sentiment" and advises waiting for alignment.

Key Price Levels (Observational Only)